Jackie O'Brien
Director & UK-IPN Program Chair,
UK Industry Pharmacogenomics Network
A former nurse Jackie has industry experience working with pharmaceutical companies, medical device companies, large blue chip organisations through to the smallest of SMEs. She is currently leading the Industry work package for the Centre of Excellence in Regulatory Science and Innovation for Pharmacogenomics (CERSI-PGx) and is also the Director of the UK Industry Pharmacogenomics Network.
Founded in 2023 the UK Industry Pharmacogenomics Network (UK-IPN) is a pioneering collaborative designed to support and empower the life science industry in advancing pharmacogenomic testing as an integral part of the UK healthcare system. It brings together companies with a vested interest in pharmacogenomics; whether as manufacturers of medicines, medical devices, software solutions, or diagnostic tools - providing a united industry voice to navigate the evolving regulatory landscape and integration pathways within the NHS.
Sessions
-
09-May-2026Medicines Optimisation WorkshopsCentre for Excellence in Regulatory Science and Innovation in Pharmacogenomics (CERSI-PGx)

